Combination antifungal therapy for the treatment of invasive yeast and mold infections (Q37000091)

17 August 2017

title

Combination antifungal therapy for the treatment of invasive yeast and mold infections (English)

1 reference

17 August 2017

John W Baddley

1

1 reference

17 August 2017

Peter G Pappas

series ordinal

2

1 reference

17 August 2017

publication date

1 November 2007

1 reference

Current infectious disease reports

17 August 2017

published in

1 reference

17 August 2017

volume

9

1 reference

17 August 2017

issue

6

1 reference

17 August 2017

page(s)

448-456

1 reference

In vitro determination of optimal antifungal combinations against Cryptococcus neoformans and Candida albicans

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11908-007-0069-1

Interactions among amphotericin B, 5-fluorocytosine, ketoconazole, and miconazole against pathogenic fungi in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-007-0069-1

Combination therapy of murine invasive candidiasis with fluconazole and amphotericin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-007-0069-1

Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-007-0069-1

Fluconazole combined with flucytosine for treatment of cryptococcal meningitis in patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-007-0069-1

A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects.

21 January 2018

1 reference

12 December 2020

In-vitro interactions of itraconazole with flucytosine against clinical isolates of Cryptococcus neoformans

1 reference

12 December 2020

Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks.

1 reference

12 December 2020

A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis. National Institute of Allergy and Infectious Diseases Mycoses Study Group

1 reference

12 December 2020

Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial

1 reference

12 December 2020

A randomized study comparing fluconazole with amphotericin B/5-flucytosine for the treatment of systemic Candida infections in intensive care patients

1 reference

12 December 2020

Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group

1 reference

12 December 2020

International, open-label, noncomparative, clinical trial of micafungin alone and in combination for treatment of newly diagnosed and refractory candidemia.

1 reference

12 December 2020

Preclinical assessment of the efficacy of mycograb, a human recombinant antibody against fungal HSP90

1 reference

12 December 2020

Evaluation of single-drug and combination antifungal therapy in an experimental model of candidiasis in rabbits with prolonged neutropenia

1 reference

12 December 2020

Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies

1 reference

12 December 2020

The changing face of fungal infections in health care settings

1 reference

12 December 2020

Evaluation of amphotericin B and flucytosine in combination against Candida albicans and Cryptococcus neoformans using time-kill methodology

1 reference

12 December 2020

Antifungal Action of Amphotericin B in Combination with Other Polyene or Imidazole Antibiotics

1 reference

12 December 2020

Comparative efficacies of conventional amphotericin b, liposomal amphotericin B (AmBisome), caspofungin, micafungin, and voriconazole alone and in combination against experimental murine central nervous system aspergillosis

1 reference

12 December 2020

Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis.

1 reference

12 December 2020

Combination therapy in treatment of experimental pulmonary aspergillosis: synergistic interaction between an antifungal triazole and an echinocandin

1 reference

12 December 2020

Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study

1 reference

12 December 2020

Synergism of Polyene Antibiotics with 5-Fluorocytosine

1 reference

12 December 2020

Pneumocandin L-743,872 enhances the activities of amphotericin B and fluconazole against Cryptococcus neoformans in vitro

1 reference

12 December 2020

Combination and sequential antifungal therapy for invasive aspergillosis: review of published in vitro and in vivo interactions and 6281 clinical cases from 1966 to 2001.

1 reference

12 December 2020

Combination Therapy of Experimental Candidiasis, Cryptococcosis and Aspergillosis in Mice

1 reference

12 December 2020

Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group

1 reference

12 December 2020

In vitro susceptibility and synergy studies of Aspergillus species to conventional and new agents.

1 reference

12 December 2020

Interactions between triazoles and amphotericin B against Cryptococcus neoformans

1 reference

12 December 2020

Combination antifungal therapy

1 reference

12 December 2020

Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy

1 reference

12 December 2020

Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America

1 reference

12 December 2020

Refractory Aspergillus pneumonia in patients with acute leukemia: successful therapy with combination caspofungin and liposomal amphotericin

1 reference

12 December 2020

Guidelines for treatment of candidiasis

1 reference

12 December 2020

Combination therapy with antifungal drugs

1 reference

12 December 2020

Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial

1 reference

12 December 2020

Rationale for combination antifungal therapy

1 reference

12 December 2020

Effect of severity of meningitis on fungicidal activity of flucytosine combined with fluconazole in a murine model of cryptococcal meningitis

1 reference

12 December 2020

In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp.

1 reference

12 December 2020

Antifungal activities of fluconazole, caspofungin (MK0991), and anidulafungin (LY 303366) alone and in combination against Candida spp. and Crytococcus neoformans via time-kill methods

1 reference

12 December 2020

Comparison of Etest, chequerboard dilution and time-kill studies for the detection of synergy or antagonism between antifungal agents tested against Candida species

1 reference

12 December 2020

In vitro interaction of caspofungin acetate with voriconazole against clinical isolates of Aspergillus spp.

1 reference

12 December 2020

Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America

1 reference

12 December 2020

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

1 reference

12 December 2020

Antifungal combination therapy: clinical potential

1 reference

12 December 2020

Combination antifungal therapy for invasive aspergillosis

1 reference

12 December 2020

Triazole-polyene antagonism in experimental invasive pulmonary aspergillosis: in vitro and in vivo correlation

1 reference

12 December 2020

Efficacy of caspofungin alone and in combination with voriconazole in a Guinea pig model of invasive aspergillosis

1 reference

12 December 2020

Combined antifungal therapy in a murine infection by Candida glabrata

1 reference

12 December 2020

A Comparison of Amphotericin B Alone and Combined with Flucytosine in the Treatment of Cryptoccal Meningitis

1 reference

12 December 2020

A randomized, blinded, multicenter trial of lipid-associated amphotericin B alone versus in combination with an antibody-based inhibitor of heat shock protein 90 in patients with invasive candidiasis.

1 reference

12 December 2020

Comparative study of six antifungal treatments in an experimental model of murine cryptococcosis

1 reference

12 December 2020

Combination Therapy of Experimental Histoplasmosis and Cryptococcosis with Amphotericin Band Ketoconazole

1 reference

12 December 2020

Combined Amphotericin B-Flucytosine Therapy in Aspergillus Pneumonia

1 reference

12 December 2020

10.1007/S11908-007-0069-1

Identifiers

DOI

1 reference

17 August 2017

1 reference